These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Kiefer FW; Neschen S; Pfau B; Legerer B; Neuhofer A; Kahle M; Hrabé de Angelis M; Schlederer M; Mair M; Kenner L; Plutzky J; Zeyda M; Stulnig TM Diabetologia; 2011 Aug; 54(8):2132-42. PubMed ID: 21562757 [TBL] [Abstract][Full Text] [Related]
3. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065 [TBL] [Abstract][Full Text] [Related]
4. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Kiefer FW; Zeyda M; Todoric J; Huber J; Geyeregger R; Weichhart T; Aszmann O; Ludvik B; Silberhumer GR; Prager G; Stulnig TM Endocrinology; 2008 Mar; 149(3):1350-7. PubMed ID: 18048491 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of high-fat-diet rich in lard oil or soybean oil on osteopontin expression and inflammation of adipose tissue in diet-induced obese rats. Wang X; Cheng M; Zhao M; Ge A; Guo F; Zhang M; Yang Y; Liu L; Yang N Eur J Nutr; 2013 Apr; 52(3):1181-9. PubMed ID: 22847642 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. Chapman J; Miles PD; Ofrecio JM; Neels JG; Yu JG; Resnik JL; Wilkes J; Talukdar S; Thapar D; Johnson K; Sears DD PLoS One; 2010 Nov; 5(11):e13959. PubMed ID: 21103061 [TBL] [Abstract][Full Text] [Related]
7. Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity. Tardelli M; Zeyda K; Moreno-Viedma V; Wanko B; Grün NG; Staffler G; Zeyda M; Stulnig TM Mol Metab; 2016 Nov; 5(11):1131-1137. PubMed ID: 27818939 [TBL] [Abstract][Full Text] [Related]
8. A novel benzenediamine derivative FC98 reduces insulin resistance in high fat diet-induced obese mice by suppression of metaflammation. Chen C; Zhang W; Shi H; Zhuo Y; Yang G; Zhang A; Hou Y; Xiang Tan R; Li E Eur J Pharmacol; 2015 Aug; 761():298-308. PubMed ID: 26086863 [TBL] [Abstract][Full Text] [Related]
9. Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice. Lancha A; Rodríguez A; Catalán V; Becerril S; Sáinz N; Ramírez B; Burrell MA; Salvador J; Frühbeck G; Gómez-Ambrosi J PLoS One; 2014; 9(5):e98398. PubMed ID: 24871103 [TBL] [Abstract][Full Text] [Related]
11. NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production. Wu J; Wu D; Zhang L; Lin C; Liao J; Xie R; Li Z; Wu S; Liu A; Hu W; Xi Y; Bu S; Wang F J Leukoc Biol; 2020 Apr; 107(4):589-596. PubMed ID: 31829469 [TBL] [Abstract][Full Text] [Related]
13. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Khan IM; Perrard XY; Brunner G; Lui H; Sparks LM; Smith SR; Wang X; Shi ZZ; Lewis DE; Wu H; Ballantyne CM Int J Obes (Lond); 2015 Nov; 39(11):1607-18. PubMed ID: 26041698 [TBL] [Abstract][Full Text] [Related]
14. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Bertola A; Deveaux V; Bonnafous S; Rousseau D; Anty R; Wakkach A; Dahman M; Tordjman J; Clément K; McQuaid SE; Frayn KN; Huet PM; Gugenheim J; Lotersztajn S; Le Marchand-Brustel Y; Tran A; Gual P Diabetes; 2009 Jan; 58(1):125-33. PubMed ID: 18952835 [TBL] [Abstract][Full Text] [Related]
15. Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice. Grün NG; Strohmeier K; Moreno-Viedma V; Le Bras M; Landlinger C; Zeyda K; Wanko B; Leitner L; Staffler G; Zeyda M; Stulnig TM Immunol Lett; 2016 Nov; 179():85-94. PubMed ID: 27639826 [TBL] [Abstract][Full Text] [Related]
16. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat. den Hartigh LJ; Goodspeed L; Wang SA; Kenerson HL; Omer M; O'Brien KD; Ladiges W; Yeung R; Subramanian S Exp Physiol; 2018 Nov; 103(11):1469-1480. PubMed ID: 30117227 [TBL] [Abstract][Full Text] [Related]
17. Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function. Zeyda M; Gollinger K; Todoric J; Kiefer FW; Keck M; Aszmann O; Prager G; Zlabinger GJ; Petzelbauer P; Stulnig TM Endocrinology; 2011 Jun; 152(6):2219-27. PubMed ID: 21467192 [TBL] [Abstract][Full Text] [Related]
18. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance. Perfield JW; Lee Y; Shulman GI; Samuel VT; Jurczak MJ; Chang E; Xie C; Tsichlis PN; Obin MS; Greenberg AS Diabetes; 2011 Apr; 60(4):1168-76. PubMed ID: 21346175 [TBL] [Abstract][Full Text] [Related]
19. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. Guo H; Xia M; Zou T; Ling W; Zhong R; Zhang W J Nutr Biochem; 2012 Apr; 23(4):349-60. PubMed ID: 21543211 [TBL] [Abstract][Full Text] [Related]